• Innovative Biological anti-Fibrosis Drugs Developed in Chengdu Huitai Biomedicine Company appeared in the annual conference of the American Thoracic Society (ATS) in 2020


    HTPEP-001, a new drug being developed by the company, was once again recognized by the international authoritative academic conference

    MORE >
  • Huitai‘s second IPF International Academic conference in 2020


    IPF International Symposium is an annual conference held by the company around the IPF project and the latest progress in the global IPF research field, focusing on the non clinical research frontier ...

    MORE >
  • Huitai 2018 IPF Expert Academic conference


    Chengdu Huitai Biomedicine Company (referred to as "Huitai") successfully held the company's first idiopathic pulmonary fibrosis (IPF) expert Academic conference in Chengdu High-tech Zone, on November...

    MORE >
  • 1
  • 2
  • 3